Rita Thakkar - 15 Jan 2026 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role: Chief Accounting Officer
Signature: /s/ Mardi Dier, as Attorney-in-Fact
Issuer symbol: MDGL
Transactions as of: 15 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 20 Jan 2026, 17:31:15 UTC
Previous filing: 20 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Thakkar Rita	Chief Accounting Officer	C/O MADRIGAL PHARMACEUTICALS, INC., 200 BARR HARBOR DRIVE, SUITE 200, WEST CONSHOHOCKEN	/s/ Mardi Dier, as Attorney-in-Fact	20 Jan 2026	0002105550

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDGL	Common Stock	Award	$0	+2,398		$0.000000	2,398	15 Jan 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDGL	Stock Option (Right to Buy)	Award	$0	+1,826		$0.000000	1,826	15 Jan 2026	Common Stock	1,826	$495.88	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units, which vest as to 25% of the shares on each of January 15, 2027, January 15, 2028, January 15, 2029 and January 15, 2030, provided the Reporting Person continues in service with the Issuer on each such date.
F2	The option vests as to 25% of the shares on the first anniversary of the date of grant (January 15, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.